Eli Lilly announced its…
Eli Lilly announced its amylin-Zepbound combination eloraTZP resulted in 23.3% [...]
Base editing biotech Beam…
Base editing biotech Beam Therapeutics is suing one of its [...]
Merck & Co. touted a win for…
Merck & Co. touted a win for its anti-TL1A antibody [...]
GSK is paying Wave Life Sciences…
GSK is paying Wave Life Sciences $12 million upfront to [...]
Connect Biopharma has pointed to…
Connect Biopharma has pointed to phase 2 data for its [...]
Zealand Pharma has shared primary…
Zealand Pharma has shared primary endpoint data on Roche-partnered petrelintide, [...]
Amgen has shed light on its phase…
Amgen has shed light on its phase 2 lupus win, [...]
Eli Lilly has shared detailed data…
Eli Lilly has shared detailed data from a phase 3 [...]
As antiviral specialist Enanta…
As antiviral specialist Enanta Pharmaceuticals endeavors to expand into immunology, [...]
Highlight Therapeutics touted…
Highlight Therapeutics touted positive topline results in patients with localized [...]